147 related articles for article (PubMed ID: 17091771)
1. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
Engi H; Sakagami H; Kawase M; Parecha A; Manvar D; Kothari H; Adlakha P; Shah A; Motohashi N; Ocsovszki I; Molnár J
In Vivo; 2006; 20(5):637-43. PubMed ID: 17091771
[TBL] [Abstract][Full Text] [Related]
2. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
3. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells.
Baráth Z; Radics R; Spengler G; Ocsovszki I; Kawase M; Motohashi N; Shirataki Y; Shah A; Molnár J
In Vivo; 2006; 20(5):645-9. PubMed ID: 17091772
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
Wesolowska O; Molnár J; Motohashi N; Michalak K
Anticancer Res; 2002; 22(5):2863-7. PubMed ID: 12530010
[TBL] [Abstract][Full Text] [Related]
6. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity.
Foroughinia F; Javidnia K; Amirghofran Z; Mehdipour A; Miri R
J Pharm Pharmacol; 2008 Nov; 60(11):1481-9. PubMed ID: 18957169
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones.
Ferreira MJ; Gyémánt N; Madureira AM; Molnár J
Anticancer Res; 2005; 25(5):3259-62. PubMed ID: 16101136
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
[TBL] [Abstract][Full Text] [Related]
11. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
Ferreira MJ; Gyémánt N; Madureira AM; Tanaka M; Koós K; Didziapetris R; Molnár J
Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
[TBL] [Abstract][Full Text] [Related]
12. Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells.
Madureira AM; Spengler G; Molnár A; Varga A; Molnár J; Abreu PM; Ferreira MJ
Anticancer Res; 2004; 24(2B):859-64. PubMed ID: 15161038
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyridines and atypical MDR: a novel perspective of designing general reversal agents for both typical and atypical MDR.
Miri R; Mehdipour A
Bioorg Med Chem; 2008 Sep; 16(18):8329-34. PubMed ID: 18701304
[TBL] [Abstract][Full Text] [Related]
14. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma infection and cell free extract of the parasites are able to reverse multidrug resistance of mouse lymphoma and human gastric cancer cells in vitro.
Varga A; Sokolowska-Kohler W; Presber W; Von Baehr V; Von Baehr R; Lucius R; Volk D; Nacsa J; Hever A
Anticancer Res; 1999; 19(2A):1317-24. PubMed ID: 10368693
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors.
Voigt B; Coburger C; Monár J; Hilgeroth A
Bioorg Med Chem; 2007 Aug; 15(15):5110-3. PubMed ID: 17533131
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
[TBL] [Abstract][Full Text] [Related]
18. New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors.
Zhou XF; Zhang L; Tseng E; Scott-Ramsay E; Schentag JJ; Coburn RA; Morris ME
Drug Metab Dispos; 2005 Mar; 33(3):321-8. PubMed ID: 15585608
[TBL] [Abstract][Full Text] [Related]
19. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
[TBL] [Abstract][Full Text] [Related]
20. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
